Trial Outcomes & Findings for Combined Spinal-Epidural Temperature and Duration of Action (NCT NCT02020304)

NCT ID: NCT02020304

Last Updated: 2018-09-10

Results Overview

length of time in minutes the combined spinal epidural dose duration is calculated from the time of administration until the request is made for additional analgesia (\~1.5-3 hours) post dose. The subjects epidural is then dosed as per standard of care.

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

58 participants

Primary outcome timeframe

up to 3 hours

Results posted on

2018-09-10

Participant Flow

Participant milestones

Participant milestones
Measure
Room Temperature
room temperature combined spinal epidural dose (60-75 degrees F) combined spinal epidural: Combined Spinal Epidural
Refrigerated Temperature
refrigerated temperature combined spinal epidural dose (\~\<43 degrees F) combined spinal epidural: Combined Spinal Epidural
Overall Study
STARTED
30
28
Overall Study
COMPLETED
27
26
Overall Study
NOT COMPLETED
3
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Combined Spinal-Epidural Temperature and Duration of Action

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Room Temperature
n=27 Participants
room temperature combined spinal epidural dose (60-75 degrees F) combined spinal epidural: Combined Spinal Epidural
Refrigerated Temperature
n=26 Participants
refrigerated temperature combined spinal epidural dose (\~\<43 degrees F) combined spinal epidural: Combined Spinal Epidural
Total
n=53 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
27 Participants
n=5 Participants
26 Participants
n=7 Participants
53 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Sex: Female, Male
Female
27 Participants
n=5 Participants
26 Participants
n=7 Participants
53 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
27 participants
n=5 Participants
26 participants
n=7 Participants
53 participants
n=5 Participants

PRIMARY outcome

Timeframe: up to 3 hours

length of time in minutes the combined spinal epidural dose duration is calculated from the time of administration until the request is made for additional analgesia (\~1.5-3 hours) post dose. The subjects epidural is then dosed as per standard of care.

Outcome measures

Outcome measures
Measure
Room Temperature
n=27 Participants
room temperature combined spinal epidural dose (60-75 degrees F) combined spinal epidural: Combined Spinal Epidural
Refrigerated Temperature
n=26 Participants
refrigerated temperature combined spinal epidural dose (\~\<43 degrees F) combined spinal epidural: Combined Spinal Epidural
Time
74 minutes
Standard Deviation 29
81 minutes
Standard Deviation 32

SECONDARY outcome

Timeframe: from time of CSE administration

Population: number of subjects who achieved a VAS pain score of \</=3 at 5 minutes after CSE injection

Outcome measures

Outcome measures
Measure
Room Temperature
n=27 Participants
room temperature combined spinal epidural dose (60-75 degrees F) combined spinal epidural: Combined Spinal Epidural
Refrigerated Temperature
n=26 Participants
refrigerated temperature combined spinal epidural dose (\~\<43 degrees F) combined spinal epidural: Combined Spinal Epidural
Analgesia Onset-5 Minutes Post Injection
24 Participants
14 Participants

SECONDARY outcome

Timeframe: up to 3 hours

Population: number of subjects who achieved a VAS pain score of \</= 3 at 10 minutes after CSE injection

Outcome measures

Outcome measures
Measure
Room Temperature
n=27 Participants
room temperature combined spinal epidural dose (60-75 degrees F) combined spinal epidural: Combined Spinal Epidural
Refrigerated Temperature
n=26 Participants
refrigerated temperature combined spinal epidural dose (\~\<43 degrees F) combined spinal epidural: Combined Spinal Epidural
Analgesia Onset-10 Minutes Post Injection
25 Participants
19 Participants

SECONDARY outcome

Timeframe: up to 3 hours

Population: number of subjects who achieved a VAS pain score of \</= 3 at 15 minutes after injection

Outcome measures

Outcome measures
Measure
Room Temperature
n=27 Participants
room temperature combined spinal epidural dose (60-75 degrees F) combined spinal epidural: Combined Spinal Epidural
Refrigerated Temperature
n=26 Participants
refrigerated temperature combined spinal epidural dose (\~\<43 degrees F) combined spinal epidural: Combined Spinal Epidural
Analgesia Onset-15 Minutes Post Injection
25 Participants
24 Participants

SECONDARY outcome

Timeframe: 30 minutes

patients reporting pruritis at 30 minutes after CSE injection, self reported and measured on a scale of 0 (no itching at all) up to 10 (itching as bad as can be imagined)

Outcome measures

Outcome measures
Measure
Room Temperature
n=27 Participants
room temperature combined spinal epidural dose (60-75 degrees F) combined spinal epidural: Combined Spinal Epidural
Refrigerated Temperature
n=26 Participants
refrigerated temperature combined spinal epidural dose (\~\<43 degrees F) combined spinal epidural: Combined Spinal Epidural
Pruritus
2 units on a scale
Standard Deviation 1
1 units on a scale
Standard Deviation 2

Adverse Events

Room Temperature

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Refrigerated Temperature

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Vernon H Ross MD

Wake Forest School of Medicine

Phone: 336-718-8278

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place